OCUGEN SEEKS TO SELL 100 MN DOSES OF COVAXIN IN THE US THIS YEAR

Highlights

• The company is seeking to sell 100 million doses of COVID-19 vaccine developed by India’s Bharat Biotech, COVAXIN in the United States this year

• In an interim analysis of late-stage trial data on nearly 26,000 people in India, this COVID-19 vaccine has shown to be 81 percent effective

• Musunari also said that Ocugen had held initial talks with the US Food and Drug Administratio....